SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

10 Aug 2023 Evaluate
A decrease in the sales to Rs. 658.60 millions was observed for the quarter ended June 2023. The sales stood at Rs. 711.80 millions during the similar quarter previous year.Net Profit for the quarter ended June 2023 dipped to Rs. 1.54  millions from Rs. 38.04 millions  in the corresponding previous quarter.A decline of 23.02 millions was observed in the OP in the quarter ended June 2023 from 66.56 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 658.60 711.80 -7.47 658.60 711.80 -7.47 2730.95 2045.20 33.53
Other Income 14.82 1.73 756.65 14.82 1.73 756.65 160.86 80.27 100.40
PBIDT 23.02 66.56 -65.41 23.02 66.56 -65.41 439.99 234.40 87.71
Interest 9.52 4.95 92.32 9.52 4.95 92.32 26.72 29.53 -9.52
PBDT 13.50 61.61 -78.09 13.50 61.61 -78.09 413.27 204.87 101.72
Depreciation 11.24 10.81 3.98 11.24 10.81 3.98 44.12 43.23 2.06
PBT 2.26 50.80 -95.55 2.26 50.80 -95.55 369.15 161.64 128.38
TAX 0.72 12.76 -94.36 0.72 12.76 -94.36 56.63 44.20 28.12
Deferred Tax -0.55 -1.02 -46.08 -0.55 -1.02 -46.08 -2.09 6.73 -131.05
PAT 1.54 38.04 -95.95 1.54 38.04 -95.95 312.52 117.44 166.11
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.12 482.12 0.00
PBIDTM(%) 3.50 9.35 -62.62 3.50 9.35 -62.62 16.11 11.46 40.57

Kopran Share Price

159.60 4.70 (3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×